Cite
HARVARD Citation
Bell, G. et al. (2017). Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron. Clinical pharmacology & therapeutics. 102 (2), pp. 213-218. [Online].